Finance

Beta
Lists
NHNKY:OTCMKTS
Nihon Kohden Unsponsored ADR Representing Ord Shs
$9.76
+2.28%
(+0.22) 1D
May 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NHNKY...
Open
$9.39
High
$9.76
Low
$9.39
Mkt. cap
256.61B
Avg. vol.
31.31K
Volume
4.64K
52-wk high
$14.21
52-wk low
$8.71
Beta
0.54
Shares outstanding
170.96M
No. of employees
6K
News stories
From sources across the web
Profile
Nihon Kohden Corporation is a Tokyo-based leading manufacturer, developer and distributor of medical electronic equipment, which include EEGs, EMG measuring systems, ECGs, patient monitors, Invasive and Non-Invasive Ventilators, Defibrillators, AEDs and clinical information systems, with subsidiaries in the U.S., Europe and Asia. The company's products are now used in more than 120 countries, and it is the largest supplier of EEG products worldwide. In 1972, Takuo Aoyagi, a researcher at the company, invented and patented the basic principles of pulse oximetry. Two years later he developed the world's first pulse oximeter, the OLV-5100, which has helped improve patient safety during anaesthesia. Wikipedia
About Nihon Kohden Unsponsored ADR Representing Ord Shs
CEO-
Employees6.11K
FoundedAug 7, 1951
HeadquartersShinjuku City, Tokyo, Japan
SectorMedical device
Website-
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
50.02B
58.10B
55.89B
71.09B
Cost of goods sold
23.70B
27.62B
27.60B
34.45B
Cost of revenue
23.70B
27.62B
27.60B
34.45B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.92B
25.14B
25.90B
27.03B
Operating expense
24.89B
25.14B
25.88B
27.03B
Total operating expenses
48.60B
52.76B
53.48B
61.47B
Operating income
1.42B
5.34B
2.41B
9.61B
Other non operating income
138.00M
17.00M
85.00M
61.00M
EBT including unusual items
471.00M
6.26B
3.15B
10.05B
EBT excluding unusual items
545.00M
6.27B
5.15B
10.69B
Income tax expense
278.00M
1.87B
1.26B
1.95B
Effective tax rate
59.02%
29.92%
40.17%
19.36%
Other operating expenses
-
-
-
-
Net income
137.00M
4.39B
1.88B
8.10B
Net profit margin
0.27%
7.55%
3.37%
11.40%
Earnings per share
-
-
-
-
Interest and investment income
106.00M
91.00M
116.00M
113.00M
Interest expense
-107.00M
-39.00M
-83.00M
-112.00M
Net interest expenses
-1.00M
52.00M
33.00M
1.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.48B
6.98B
3.90B
11.25B
Gain or loss from assets sale
-
-
-
58.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer